Could a single injection stop post-surgery delirium in children?

NCT ID NCT07704437

Completed Symptom relief Sponsor: University Hospital of Split Source: ClinicalTrials.gov ↗

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This trial investigates whether a drug called remimazolam can prevent emergence delirium—a state of confusion and agitation—in children aged 3 to 12 after tonsillectomy or similar procedures. Children are randomly assigned to receive either remimazolam or a placebo (salt water) before anesthesia. The study measures delirium, pain, recovery time, and parent satisfaction.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: remimazolam, a sedative drug given by injection
What this could lead to: If effective, remimazolam could become a standard way to prevent emergence delirium in children after surgery, making recovery calmer and safer.
What could go wrong: This is an early-phase trial with a small number of children, so results may not apply broadly. Remimazolam may cause side effects like drowsiness or allergic reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EMERGENCE DELIRIUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

delirium Emergence Delirium

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EMERGENCE DELIRIUM REMIMAZOLAM TONSILLECTOMY

Contacts and locations

Show contact details

Locations

UH Split

Split, Split-Dalmatia County, 21000, Croatia

More trials for these conditions

Other studies related to the condition(s) this trial covers.